Health
Biogen Forecasts Bigger Annual Sales Decline Than Expected
This article is for subscribers only.
Biogen Inc. forecast a bigger decline in annual sales than Wall Street expected, dimming the drugmaker’s strong finish to 2024.
The company said it expects “a mid-single digit percentage” sales drop for 2025. Analysts on average called for a decline of less than 3%.